🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This extension study will assess the safety and efficacy of AIN457 versus p...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2010-08
Trial ID
NCT01090310
Mild psoriasis not only progresses to moderate-to-severe psoriasis but also...
Status
Completed
Location
The Rockefeller Univesity
Start Date
2017-05-23
Trial ID
NCT03131570
Treatments Being Tested
This study provided a comparison of secukinumab to placebo with respect to ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2017-04-18
Trial ID
NCT03055494
Treatments Being Tested
Purpose of the study was to demonstrate the efficacy of secukinumab versus ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2013-06-19
Trial ID
NCT01806597
Treatments Being Tested
Evaluate psoriasis severity and its psychosocial impact using a novel Patie...
Status
Completed
Location
Novartis Investigative Site
Start Date
2015-05-20
Trial ID
NCT02595970
Treatments Being Tested
The purpose of this study is to explore the efficacy and safety of anti-Int...
Status
Completed
Location
Technical University of Munich
Start Date
2016-04
Trial ID
NCT02733094
Treatments Being Tested
The study will assess the safety and efficacy of intravenous (10mg/kg) and ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-12
Trial ID
NCT01412944
Treatments Being Tested
Psoriasis is a chronic inflammatory skin disease characterized by scaly ind...
Status
Completed
Location
South Valley Hospitals
Start Date
2024-12-01
Trial ID
NCT06729463
Treatments Being Tested
This was a retrospective, observational study. The objective of the study i...
Status
Completed
Location
University of Verona
Start Date
2019-03-20
Trial ID
NCT03828643
Treatments Being Tested
The purpose of this study is to provide 24 - 52 week efficacy, safety and t...
Status
Completed
Location
Novartis Investigative Site
Start Date
2014-04-10
Trial ID
NCT01989468
Treatments Being Tested